News and Events

LakePharma Supplying Mount Sinai with SARS-CoV-2 Proteins for Serological Assays

LakePharma today announces that the company will be supplying the Mount Sinai Health System (Mount Sinai) recombinant SARS-CoV-2 spike proteins to the Mount Sinai Laboratory as a component in its blood test for antibody response against SARS-CoV-2, the virus that causes the COVID-19 pandemic.

Webinar recording now available - Part 2 :LakePharma Reagents & Assays for COVID-19 Antibody Response

Recording now available

Fresh Approaches to Antibody and Protein Discovery, Development, and Manufacturing

An interview by GEN with Dr. Hua Tu, CEO of LakePharma

Webinar recording now available: LakePharma Reagents & Assays for COVID-19 Antibody Response

Thank you to those who attended our webinar on April 15. Webinar Recording is available now.

Recombinant COVID-19 Virus Spike Proteins Available From LakePharma